Scott Tarriff

Scott Tarriff

Direttore/Membro del Consiglio presso
HMH Hospitals Corp, Inc.
66 anni
Health Technology
Consumer Services
Health Services

Profilo

Scott L.
Tarriff
was the founder of Eagle Pharmaceuticals, Inc., founded in 2007, where the titles held included President, Chief Executive Officer & Director from 2021 to 2023.
Mr. Tarriff currently holds the position of Director at HMH Hospitals Corp, Inc. Former positions include President & Chief Executive Officer at Endo Generics Holdings, Inc. in 2007; President, Chief Executive Officer & Director at Par Pharmaceutical, Inc. from 2003 to 2006; Non-Executive Chairman at Alaunos Therapeutics, Inc. from 2019 to 2020; Senior Director-Marketing at Bristol Myers Squibb Co.; Director at Clinical Data, Inc. from 2009 to 2011; Independent Director at Theriva Biologics, Inc. from 2012 to 2020; and Director at Hackensack Meridian Health, Inc. Education includes undergraduate studies at The Pennsylvania State University and an MBA from Rider University.

Posizioni attive di Scott Tarriff

SocietàPosizioneInizio
Direttore/Membro del Consiglio -

Precedenti posizioni note di Scott Tarriff

SocietàPosizioneFine
EAGLE PHARMACEUTICALS, INC. Fondatore 27/11/2023
ALAUNOS THERAPEUTICS, INC. Presidente 16/12/2020
THERIVA BIOLOGICS, INC. Direttore/Membro del Consiglio 11/11/2020
Direttore/Membro del Consiglio 12/04/2011
PAR PHARMACEUTICAL COMPANIES, INC. Presidente 01/01/2007
Vedi nel dettaglio l'esperienza di Scott Tarriff

Formazione di Scott Tarriff

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

52

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Services

Health Technology

Health Technology

Health Technology

Health Services

  1. Mercati
  2. Insiders
  3. Scott Tarriff
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA